Evidence map›Paper›PMID 42584515›Full record

ReviewCurrent urology reports2026

Intravesical Recurrence of Upper Tract Urothelial Carcinoma: Strategies for Prevention.

Lingmin Song, Margaret Meagher, Ava Saidian, Amirali Salmasi, Sarah Azari, Mai Dabbas, Aditya Bagrodia

Abstract readReview
In one paragraph

Review in Current urology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingmin SongDepartment of Urology, Ningbo Hospital of Integrated Tranditional Chinese and Western Medicine, Zhejiang, China.
Margaret MeagherDepartment of Urology, University of California San Diego, San Diego, CA, USA.
Ava SaidianDepartment of Urology, University of Tennessee Health Sciences System, Memphis, TN, USA.
Amirali SalmasiDepartment of Urology, University of California San Diego, San Diego, CA, USA.
Sarah AzariDepartment of Urology, University of California San Diego, San Diego, CA, USA.
Mai DabbasDepartment of Urology, University of California San Diego, San Diego, CA, USA.
Aditya BagrodiaDepartment of Urology, University of California San Diego, San Diego, CA, USA. bagrodia@health.ucsd.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review focuses on intravesical recurrence (IVR) of upper tract urothelial carcinoma (UTUC). RECENT

findingsWe explore epidemiology, risk factors, mechanisms of tumor cell seeding, molecular pathways, genetic predispositions, and related factors of UTUC. Diagnostic techniques, strategies managing disease and reducing recurrence, as well as controversies and challenges in UTUC management are discussed. By synthesizing the latest research findings, this review aims to provide a comprehensive understanding of UTUC IVR which can guide clinical practice and future research efforts.

Indexed as

Carcinoma, Transitional CellKidney NeoplasmsNeoplasm Recurrence, LocalUreteral NeoplasmsUrinary Bladder NeoplasmsHumansNeoplasm SeedingRisk FactorsBladder recurrenceSeedingUrothelial carcinoma

Identifiers

PMID42584515
PMCPMC13468967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.